髋部骨折后男女性肌少症患病率纵向趋势:三种定义比较
本研究为前瞻性观察研究,纳入巴尔的摩髋部研究第七队列82名男性和78名女性(≥65岁,非病理性髋部骨折术后),在基线及术后2、6、12个月评估肌少症。结果显示EWGSOP和IWGS定义的患病率最高(男性62%-69%,女性42%-62%),FNIH定义则低得多(男性15%-19%,女性5%-12%);男性各定义患病率随时间稳定,女性FNIH定义在6个月显著增加(P=.03);总体而言骨折后一年内肌少症未见减少。
要点
- 髋部骨折后肌少症患病率因定义而异,EWGSOP/IWGS高,FNIH低
- 男性患病率一年内稳定,女性FNIH定义在6个月显著增加
- 骨折后一年内肌少症总体未见减少,部分恢复部分新发
核心结论
- EWGSOP和IWGS定义的肌少症患病率远高于FNIH定义,骨折后一年内肌少症未见总体减少。
研究设计与样本
- 前瞻性观察研究,巴尔的摩髋部研究第七队列,82名男性和78名女性,年龄≥65岁,非病理性髋部骨折术后。
主要发现
- EWGSOP和IWGS患病率最高(男性62%-69%,女性42%-62%),FNIH患病率男性15%-19%、女性5%-12%。
- EWGSOP与IWGS定义间一致性极好,FNIH与二者一致性差。
- 男性各定义患病率随时间稳定;女性FNIH定义2个月最低,6个月显著增加(P=.03),12个月仍较高。
- 性别差异因时间点和定义而异,有差异时男性患病率高于女性(P<.05)。
- 部分参与者肌少症恢复,部分新发肌少症。
关键数值与推荐
- 采用EWGSOP、IWGS和FNIH三种肌少症定义进行评估。
- 女性FNIH定义患病率从2个月到6个月显著增加(P=.03)。
- 性别差异有统计学意义时男性患病率更高(P<.05)。
临床怎么用
- 临床评估髋部骨折后肌少症时需注意定义差异,EWGSOP/IWGS可能高估患病率。
- 女性患者使用FNIH定义时需关注6个月时点的患病率增加。
- 骨折后一年内应持续监测肌少症状态,部分患者可恢复但亦有新发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: While sarcopenia is prevalent after hip fracture in the acute postfracture period, little is known about the prevalence after discharge. This study assessed longitudinal trends in sarcopenia prevalence over 12 months after hip fracture using three different operational definitions. DESIGN: Prospective observational study. SETTING: Baltimore Hip Studies seventh cohort. PARTICIPANTS: A total of 82 men and 78 women, aged 65 years and older, with surgical repair of a nonpathological hip fracture. MEASUREMENTS: Baseline assessment included a dual-energy X-ray absorptiometry scan and interview. Follow-up assessments, which additionally included performance measures, occurred 2, 6, and 12 months after admission. Using these measures, three sarcopenia definitions were assessed over the year following hip fracture: European Working Group on Sarcopenia in Older Persons (EWGSOP), International Working Group on Sarcopenia (IWGS), and Foundation for the National Institutes of Health (FNIH). RESULTS: EWGSOP and IWGS provided the highest prevalence of sarcopenia (62%-69% in men, 42%-62% in women), while prevalence by FNIH was much lower for men (15%-19%) and women (5%-12%). For both men and women, the agreement between EWGSOP and IWGS definitions was excellent, and FNIH showed poor agreement with them, supported by various statistical measures across first-year follow-up. Prevalence was stable over time in men by all definitions, while the prevalence in women by FNIH was lowest at 2 months, significantly increased at 6 months (P = .03), and remained higher at 12 months. Whether sarcopenia prevalence differed significantly by sex varied by time point and definition; however, when different, men had a higher prevalence than women (P < .05). While some participants recovered from sarcopenia over time, some also became newly sarcopenic. CONCLUSION: The prevalence of sarcopenia after fracture differed greatly for EWGSOP and IWGS compared to FNIH. Overall, there appeared to be no reduction in sarcopenia over the year after hip fracture, regardless of definition. Future research should examine the relationship between sarcopenia prevalence and functional recovery. J Am Geriatr Soc 68:1537-1544, 2020.
引用
- Chiles Shaffer N, Huang Y, Abraham DS, et al. Comparing Longitudinal Sarcopenia Trends by Definitions Across Men and Women After Hip Fracture. J Am Geriatr Soc. 2020. PMID: 32239496. doi:10.1111/jgs.16417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。